obsolete_alopecia:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
364 |
4. Check minimum number of eventsNone |
364 |
5. Include endpoints |
364 |
6. Filter based on genotype QC (FinnGen only) |
347 |
Control definitions (FinnGen only)
- Control exclude
- L12_DISORDSKINAPPENDIX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L60-L75
- Name in latin
- Alia alopecia non cicatrisans
Similar endpoints
↥List of similar endpoints to
Other nonscarring hair loss
based on the number of shared cases.
Similar with more cases:
- Disorders of skin appendages
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2372 | 2134 | 224 |
| Only index persons | 2265 | 2061 | 204 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.01 |
| Only index persons | 0.07 | 0.08 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 38.44 | 40.23 | 21.33 |
| Only index persons | 39.24 | 40.85 | 22.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 347 | 335 | 12 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.01 |
| Median age at first event (years) | 46.12 | 46.49 | 35.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 364
- Matched controls
- 3640
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L65.9
ICD-10 Finland
Nonscarring hair loss, unspecified
857.5
222.6
197
5
L65.8
ICD-10 Finland
Other specified nonscarring hair loss
403.8
94.6
91
*
C03DA01
ATC
spironolactone; oral
10.5
88.8
119
161
L65.0
ICD-10 Finland
Telogen effluvium
891.1
76.1
72
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.9
41.0
71
123
L65
ICD-10 Finland
Other nonscarring hair loss
141.0
36.4
38
*
L64.9
ICD-10 Finland
Androgenic alopecia, unspecified
291.5
27.1
27
*
D07AC13
ATC
mometasone; topical
3.3
26.7
160
702
D07AC01
ATC
betamethasone; topical
3.2
26.1
184
885
L63.9
ICD-10 Finland
Alopecia areata, unspecified
72.6
24.2
27
*
D07AD01
ATC
clobetasol; topical
3.3
20.4
93
339
L70.0
ICD-10 Finland
Acne vulgaris
9.0
20.4
26
31
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
18.7
132
612
L63.8
ICD-10 Finland
Other alopecia areata
177.8
16.6
17
*
E0000UV, ,
ATC
2.5
16.5
197
1164
J01AA04
ATC
lymecycline; systemic
3.1
16.4
83
319
L65.2
ICD-10 Finland
Alopecia mucinosa
+∞
13.6
13
*
L04AX01
ATC
azathioprine; systemic
5.5
13.2
26
50
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
12.9
99
468
D07XC01
ATC
betamethasone; topical
3.2
12.9
57
201
H03AA01
ATC
levothyroxine sodium; systemic
2.4
12.7
126
668
S23
ICPC
Hair loss/baldness
18.1
12.6
19
11
D06BX01
ATC
metronidazole; topical
3.0
12.5
63
239
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
12.1
136
757
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.7
11.4
27
61
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.3
10.3
92
461
H02AB06
ATC
prednisolone; systemic
2.0
9.9
180
1184
L68.0
ICD-10 Finland
Hirsutism
56.5
9.7
11
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.3
9.6
25
61
H04.10
ICD-10 Finland
Dry eye syndrome
2.6
9.6
64
280
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
9.1
91
476
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.0
8.7
153
982
L21.0
ICD-10 Finland
Seborrhoea capitis
12.0
8.6
15
13
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.6
165
1091
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.3
8.6
72
349
R53
ICD-10 Finland
Malaise and fatigue
2.1
8.6
109
624
L73.8
ICD-10 Finland
Other specified follicular disorders
28.3
8.5
11
*
L63.0
ICD-10 Finland
Alopecia (capitis) totalis
+∞
8.4
8
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
8.3
170
1146
J02AC01
ATC
fluconazole; systemic
1.9
8.2
196
1388
L63
ICD-10 Finland
Alopecia areata
25.6
7.6
10
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
7.6
40
155
D02AX
ATC
Other emollients and protectives
4.4
7.6
19
45
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.9
7.5
16
21
XQ800
NOMESCO Finland
Prick test
2.7
7.4
41
163
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
7.4
35
128
XQ845
NOMESCO Finland
Dermatoscopy
8.2
7.2
15
19
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
7.2
103
611
D10BA01
ATC
isotretinoin; oral
2.7
7.1
39
154
G04CB01
ATC
finasteride; oral
10.3
7.1
13
13
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
7.0
49
218
SPAT1263
SPAT
Sampling
1.8
6.8
165
1153
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.7
121
771
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
6.6
64
328
XG410
NOMESCO Finland
Flow-volume spirometry
3.9
6.4
19
51
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.4
126
822
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
6.3
77
430
UJF32
NOMESCO Finland
Coloscopy
1.9
6.3
87
507
A04
ICPC
Weakness/tiredness general
2.1
6.3
64
334
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
6.2
36
146
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.2
122
795
L71
ICD-10 Finland
Rosacea
5.9
6.2
16
28
JHB00
NOMESCO Finland
Hemorrhoidectomy
4.2
6.1
16
39
H02AB07
ATC
prednisone; oral
2.2
6.1
54
266
J01FF01
ATC
clindamycin; systemic
1.9
6.0
100
618
T78.4
ICD-10 Finland
Allergy, unspecified
2.9
6.0
29
107
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
221
1316
2.73
19.17
2.7
2.3
78.78
76.95
nmol/l
0.40
209
1192
185
1058
2.52
16.70
2.2
1.8
100.96
98.90
pmol/l
0.20
104
530
245
1625
2.55
15.65
3.8
2.7
91.89
70.06
ug/l
1.58
237
1517
206
1275
2.42
15.15
8.4
6.1
1.23
1.22
mmol/l
0.36
189
1079
332
2601
4.14
15.10
6.1
4.3
14.58
14.49
pmol/l
0.29
315
2397
180
1077
2.33
13.96
6.3
4.2
36.51
36.48
g/l
0.02
167
1005
149
851
2.27
12.59
1.5
1.3
1.89
1.41
u/ml
0.19
36
223
219
1480
2.20
11.98
7.5
4.9
56.03
56.56
%
0.31
207
1382
220
1492
2.20
11.89
7.8
5.1
30.04
29.52
%
0.34
209
1395
181
1142
2.16
11.71
7.3
5.4
1.23
1.22
mmol/l
0.89
170
1043
241
1734
2.15
10.69
10.2
7.7
3.83
3.95
e9/l
0.41
220
1516
291
2277
2.39
10.21
5.8
3.7
11.44
10.50
mm/h
0.56
279
2095
34
107
3.40
9.16
2.3
2.1
—
—
—
0
0
152
963
1.99
9.11
3.5
2.9
2.36
2.36
mmol/l
0.13
136
850
345
3000
3.87
8.68
7.3
5.0
1.68
2.17
mu/l
0.67
334
2801
120
714
2.02
8.47
2.7
2.0
2.49
2.92
mg/l
1.29
103
602
61
286
2.36
7.81
2.3
2.0
411.35
384.68
nmol/l
0.45
52
265
124
766
1.94
7.75
2.5
1.9
115.37
220.07
u/l
0.66
113
727
59
274
2.38
7.72
7.6
5.5
1.06
1.04
mmol/l
0.17
52
253
87
475
2.09
7.68
2.8
2.4
2.42
2.44
mmol/l
0.42
79
410
213
1568
1.86
7.66
4.5
4.2
6.54
6.32
mmol/l
0.63
200
1403
81
436
2.10
7.40
1.7
1.7
1186.77
1174.41
nmol/l
0.04
66
323
82
450
2.06
7.10
5.8
3.3
430.67
197.80
ng/l
0.25
51
284
23
68
3.54
6.81
1.3
1.2
—
—
—
0
0
64
328
2.15
6.59
3.8
2.3
23.29
23.62
%
0.07
57
281
17
42
4.20
6.43
1.1
1.4
—
—
—
0
0
43
192
2.41
6.11
4.8
3.8
90.85
75.21
ng/l
0.48
35
169
98
603
1.86
5.99
1.7
1.4
21.59
22.08
nmol/l
0.10
84
511
91
547
1.88
5.98
1.8
1.6
435.53
10684210.11
pmol/l
0.50
81
468
194
1454
1.72
5.97
7.8
5.2
9.73
9.56
umol/l
0.14
186
1368
129
864
1.76
5.94
3.0
2.4
55.00
57.95
u/l
0.45
123
794
26
91
3.00
5.91
1.4
1.3
1.20
2.59
u/ml
—
5
11
29
109
2.80
5.82
2.0
1.9
—
—
—
0
0
26
92
2.97
5.80
1.5
1.3
6.39
7.11
u/ml
—
10
19
46
219
2.26
5.66
1.4
1.2
148.12
225.29
u/ml
0.31
41
203
99
621
1.82
5.65
1.4
1.3
16.70
30.23
iu/ml
1.93
29
215
36
154
2.48
5.61
2.1
2.0
13.05
3.58
ug/l
0.65
31
131
57
299
2.07
5.50
1.2
1.3
36.66
178.53
iu/ml
7.59
24
135
24
84
2.99
5.46
1.8
2.2
1.53
1.44
g/l
0.21
24
70
149
1060
1.69
5.42
7.1
9.4
1.15
1.12
inr
0.19
52
347
27
102
2.78
5.37
1.9
1.8
—
—
—
0
0
267
2220
1.76
5.33
10.7
6.4
74.84
75.30
u/l
0.06
257
2070
343
3118
2.73
5.11
18.7
10.8
16.64
19.43
mg/l
1.05
274
2345
31
132
2.47
4.89
1.7
1.7
—
—
—
0
0
253
2098
1.68
4.82
4.0
2.8
45.80
35.27
u/l
1.10
239
1983
134
952
1.65
4.77
4.4
2.9
—
—
—
0
0
89
569
1.75
4.68
4.2
3.0
1213.71
872.92
ng/l
0.39
76
468
301
2635
1.82
4.53
6.0
4.7
38.47
38.15
mmol/mol
0.23
285
2468
14
32
4.51
4.48
1.4
1.5
—
—
—
0
0
195
1542
1.57
4.31
4.4
3.3
0.00
0.00
estimate
-0.00
40
324
102
695
1.65
4.20
2.9
1.6
0.95
0.83
mg/l
0.24
70
527
321
2886
1.95
4.17
15.2
9.8
87.06
88.09
ml/min/173m2
0.33
271
2282
54
307
1.89
4.14
3.0
2.3
7.12
5.00
umol/l
0.41
46
262
334
3051
2.15
4.05
18.6
11.6
139.58
139.72
mmol/l
0.59
329
2957
127
921
1.58
4.03
3.1
3.0
15.45
31.81
ng/l
1.09
71
496
17
59
2.97
3.95
1.2
1.3
420.64
228.68
u/ml
1.51
11
37
16
54
3.05
3.90
2.6
2.1
—
—
—
0
0
186
1481
1.52
3.82
2.7
2.4
—
—
—
0
0
63
386
1.76
3.80
2.2
1.8
—
—
—
0
0
17
61
2.87
3.74
1.2
1.3
—
—
—
0
0
12
29
4.24
3.74
1.3
1.3
—
—
—
0
0
45
251
1.90
3.66
1.7
1.3
18.41
23.13
iu/l
0.52
40
219
32
161
2.08
3.47
1.7
1.5
—
—
—
0
0
190
1540
1.49
3.46
6.0
4.5
0.00
0.00
estimate
0.50
38
310
191
1558
1.48
3.32
4.4
3.3
0.00
0.01
estimate
0.50
39
302
21
91
2.39
3.24
1.4
1.4
0.44
0.36
nmol/l
0.21
16
77
7
12
5.92
3.03
5.3
1.7
—
—
—
0
0
7
12
5.92
3.03
1.3
2.3
—
—
—
0
0
6
9
6.75
2.88
3.2
2.4
40550.00
31111.67
ug/l
—
6
9
97
709
1.50
2.84
2.5
1.9
—
—
—
0
0
121
929
1.45
2.76
1.5
1.5
—
—
—
0
0
18
79
2.34
2.72
1.3
1.5
37.36
20.76
u/l
0.58
13
68
26
134
2.01
2.68
2.0
1.7
—
—
—
0
0
84
606
1.50
2.60
1.4
1.3
17.91
11.27
u/ml
0.26
36
237
20
94
2.19
2.60
1.5
1.4
293.50
340.54
ug/g
0.49
14
52
60
403
1.59
2.56
4.2
2.6
2.90
4.09
e6/l
0.60
31
202
19
88
2.22
2.55
1.3
1.2
—
—
—
0
0
322
2992
1.66
2.49
5.0
4.3
2.81
2.86
mmol/l
0.39
300
2799
12
45
2.72
2.47
1.0
1.1
—
—
—
0
0
62
424
1.56
2.45
4.2
2.5
0.56
0.99
e6/l
1.63
32
222
344
3261
2.00
2.42
14.1
8.7
24.49
23.69
u/l
0.50
339
3152
21
104
2.08
2.41
1.1
1.3
7.55
11.57
u/l
1.10
14
89
9
27
3.39
2.41
1.4
1.2
—
—
—
0
0
9
27
3.39
2.41
1.4
1.2
—
—
—
0
0
9
27
3.39
2.41
1.4
1.2
—
—
—
0
0
19
91
2.15
2.37
1.3
1.4
—
—
—
0
0
11
39
2.88
2.36
1.2
1.4
—
—
—
0
0
43
273
1.65
2.30
2.7
2.2
28.92
31.80
u/l
0.29
36
228
13
53
2.51
2.30
5.0
3.6
—
204.00
—
0
6
319
2971
1.60
2.27
4.6
3.8
4.77
4.82
mmol/l
0.40
302
2793
7
18
3.94
2.26
1.1
1.2
—
—
—
0
0
91
688
1.43
2.20
4.9
3.7
27.47
10.64
mg/mmol
0.35
54
401
97
745
1.41
2.15
4.5
2.7
0.13
0.41
e6/l
2.59
72
550
24
131
1.89
2.13
5.6
3.5
1.38
1.65
mmol/l
0.11
18
90
12
49
2.50
2.12
1.3
1.5
—
—
—
0
0
8
25
3.25
2.10
1.1
1.3
—
—
—
0
0
17
82
2.13
2.10
1.2
1.7
—
240.00
—
0
5
38
241
1.64
2.06
2.7
3.9
5.14
9.68
ug/l
0.74
23
190
12
50
2.45
2.04
1.1
1.0
—
—
—
0
0
8
26
3.12
2.02
1.5
1.2
—
—
—
0
0
8
26
3.12
2.02
1.5
1.2
—
—
—
0
0
14
65
2.20
1.90
1.2
1.3
—
—
—
0
0
7
22
3.22
1.89
1.6
1.1
—
—
—
0
0
7
23
3.08
1.80
1.1
1.7
—
—
—
0
0
7
23
3.08
1.80
1.4
1.6
—
—
—
0
0
6
18
3.37
1.75
1.2
1.9
—
—
—
0
0
5
13
3.88
1.72
1.6
3.3
642.00
823.85
u/ml
—
5
13
13
62
2.14
1.67
3.5
3.5
59.62
58.94
%
0.07
13
62
13
62
2.14
1.67
3.5
3.2
4.05
4.37
e9/l
0.25
13
62
8
31
2.62
1.67
1.4
1.5
—
—
—
0
0
12
56
2.18
1.63
1.2
1.2
—
—
—
0
0
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
8
32
2.53
1.60
1.1
1.0
—
—
—
0
0
301
2822
1.38
1.56
4.2
3.5
1.25
1.21
mmol/l
0.59
282
2629
82
646
1.35
1.54
3.0
2.5
302.64
6188.41
umol/l
2.97
74
582
312
2949
1.41
1.48
4.7
3.8
1.56
1.56
mmol/l
0.07
293
2765
32
213
1.55
1.46
1.0
1.0
—
—
—
0
0
49
358
1.43
1.44
3.0
1.6
—
—
—
0
0
6
22
2.76
1.44
1.3
1.2
—
—
—
0
0
13
67
1.98
1.40
2.2
1.6
—
—
—
0
0
139
1196
1.26
1.34
4.5
3.3
—
—
—
0
0
84
678
1.31
1.33
3.9
3.2
1.01
1.02
kg/l
0.52
11
105
6
24
2.52
1.31
1.7
1.5
65.17
70.17
umol/l
—
6
24
6
24
2.52
1.31
1.0
1.0
—
—
—
0
0
5
18
2.80
1.29
1.0
1.3
86.60
36.28
u/l
—
5
18
5
18
2.80
1.29
1.0
1.3
156.60
83.11
u/l
—
5
18
36
254
1.46
1.28
2.2
1.8
—
—
—
0
0
8
35
2.31
1.27
1.4
1.4
—
—
—
0
0
36
255
1.46
1.26
2.1
1.8
—
—
—
0
0
259
2405
1.27
1.24
3.8
3.7
—
—
—
0
0
11
56
1.99
1.23
1.4
1.4
—
—
—
0
0
306
2904
1.34
1.23
4.7
3.9
5.80
5.68
mmol/l
0.75
285
2687
60
467
1.34
1.23
3.0
1.8
—
—
—
0
0
5
19
2.65
1.22
1.0
1.0
—
—
—
0
0
45
335
1.39
1.21
4.4
3.8
35.79
32.58
%
0.96
34
227
8
38
2.13
1.19
2.4
2.0
—
—
—
0
0
8
39
2.07
1.16
1.4
1.4
—
—
—
0
0
8
39
2.07
1.16
1.4
1.4
—
—
—
0
0
5
20
2.52
1.15
10.0
3.5
—
—
—
0
0
5
21
2.40
1.09
1.8
1.2
1.68
1.71
mmol/l
—
5
21
11
59
1.89
1.08
2.7
4.8
—
3.28
—
0
7
41
308
1.37
1.06
6.3
4.7
—
—
—
0
0
13
75
1.76
1.04
1.1
1.1
5.60
2.79
u/ml
—
6
40
5
22
2.29
1.03
1.6
1.4
—
—
—
0
0
5
22
2.29
1.03
1.6
1.4
—
—
—
0
0
7
34
2.08
1.03
1.3
1.0
—
—
—
0
0
9
47
1.94
1.03
1.0
1.3
—
—
—
0
0
5
23
2.19
0.98
1.8
2.0
—
—
—
0
0
5
23
2.19
0.98
1.6
2.5
1.96
2.97
nmol/l
—
5
23
7
36
1.96
0.97
1.1
1.6
—
—
—
0
0
10
54
1.88
0.97
1.2
1.5
—
—
—
0
0
10
54
1.88
0.97
1.2
1.5
—
—
—
0
0
7
37
1.91
0.94
1.3
1.3
—
—
—
0
0
100
860
1.22
0.94
2.0
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
56
1.81
0.88
5.7
2.2
0.50
0.36
u/ml
—
5
31
33
248
1.36
0.87
2.8
2.9
—
—
—
0
0
28
205
1.40
0.86
5.5
3.3
1.22
1.23
mmol/l
0.84
22
178
13
80
1.65
0.85
1.5
1.2
398.23
354.47
mg/l
0.18
13
74
11
67
1.66
0.76
4.6
2.4
1.64
1.46
mg/l
0.26
11
59
7
38
1.86
0.74
1.1
1.3
—
—
—
0
0
7
38
1.86
0.74
1.3
1.3
—
—
—
0
0
7
38
1.86
0.74
1.3
1.3
—
—
—
0
0
7
38
1.86
0.74
1.3
1.3
—
—
—
0
0
34
265
1.31
0.73
3.4
2.2
136.12
5043.10
u/l
2.57
13
116
5
25
2.01
0.73
1.0
1.5
—
—
—
0
0
13
84
1.57
0.73
1.5
2.1
—
—
—
0
0
13
86
1.53
0.67
3.1
2.3
0.60
0.67
%
0.32
13
86
14
95
1.49
0.65
1.0
1.2
—
—
—
0
0
21
155
1.38
0.64
1.4
1.4
—
—
—
0
0
90
796
1.17
0.63
1.8
1.6
1.25
1.33
mmol/l
0.41
79
686
14
96
1.48
0.62
1.0
1.2
—
—
—
0
0
8
50
1.61
0.61
1.6
1.2
—
—
—
0
0
25
194
1.31
0.57
2.6
1.6
—
—
—
0
0
30
240
1.27
0.56
7.7
6.1
104.47
104.03
mmol/l
0.19
30
240
16
116
1.40
0.55
2.2
1.9
2.19
5.54
iu/l
—
7
44
6
38
1.59
0.54
1.3
1.3
—
—
—
0
0
6
38
1.59
0.54
3.5
3.1
16.33
80.88
u/ml
—
6
38
14
192
0.72
0.53
1.5
1.5
—
—
—
0
0
14
100
1.42
0.52
1.9
1.6
—
—
—
0
0
11
75
1.48
0.51
1.2
1.2
23.09
64.14
e6/l
0.63
11
63
11
75
1.48
0.51
1.2
1.1
3.64
2.29
e6/l
0.27
11
59
32
386
0.81
0.49
1.5
1.5
—
—
—
0
0
91
824
1.14
0.47
5.3
3.5
0.00
0.01
estimate
0.80
37
314
7
48
1.47
0.47
2.0
2.1
12.86
13.23
%
—
7
48
27
220
1.25
0.45
1.5
1.4
—
—
—
0
0
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
8
58
1.39
0.42
2.6
2.5
26.30
24.91
mmol/l
—
8
58
5
33
1.52
0.41
1.2
1.7
4.28
11.24
u/ml
—
5
33
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
8
60
1.34
0.40
1.4
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
3.0
—
—
—
0
0
22
179
1.24
0.38
1.6
1.5
—
—
—
0
0
15
117
1.29
0.36
1.4
1.3
—
—
—
0
0
71
646
1.12
0.35
2.8
2.0
—
—
—
0
0
6
44
1.37
0.34
1.7
1.5
—
—
—
0
0
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
77
707
1.11
0.33
2.9
2.2
—
—
—
0
0
23
196
1.19
0.27
1.6
1.4
—
—
—
0
0
20
170
1.19
0.25
2.3
1.8
3.69
2.45
mg/l
0.31
13
113
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
6
49
1.23
0.20
1.8
1.9
—
—
—
0
0
7
61
1.15
0.17
1.4
1.9
—
—
—
0
0
7
62
1.13
0.17
1.3
2.5
0.00
0.00
g/l
—
7
57
7
62
1.13
0.17
1.3
2.5
0.00
0.00
g/l
—
7
57
6
78
0.77
0.15
1.0
1.2
—
—
—
0
0
12
140
0.85
0.15
1.1
1.5
—
—
—
0
0
24
261
0.91
0.12
1.2
1.4
—
—
—
0
0
7
64
1.10
0.08
1.3
2.4
0.00
0.08
g/l
—
7
59
20
215
0.93
0.08
1.5
1.4
—
—
—
0
0
12
132
0.91
0.06
1.3
1.9
—
—
—
0
0
11
99
1.11
0.06
1.2
1.3
3.14
2.85
ug/l
0.14
11
88
37
356
1.04
0.05
1.5
1.6
—
—
—
0
0
21
222
0.94
0.05
4.7
2.3
76.90
76.53
ml/min/173m2
—
10
83
11
119
0.92
0.04
12.3
8.3
0.98
1.21
%
0.52
11
119
22
230
0.95
0.03
1.5
1.5
—
—
—
0
0
17
161
1.06
0.03
1.6
1.7
—
—
—
0
0
11
118
0.93
0.03
12.4
8.3
0.76
0.65
%
0.35
11
118
11
116
0.95
0.00
12.4
8.5
92.24
94.84
%
0.45
11
116
21
216
0.97
0.00
1.4
1.4
—
—
—
0
0
21
216
0.97
0.00
1.4
1.4
—
—
—
0
0
21
215
0.98
0.00
1.4
1.4
—
—
—
0
0
16
164
0.97
0.00
1.5
1.3
186.51
275.97
miu/ml
—
6
76
0
5
0.00
-0.00
0.0
1.6
—
1.57
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
2.4
1.9
115.20
132.91
g/l
—
5
45
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
8.9
—
—
—
0
0
7
72
0.97
-0.00
1.3
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_HAIRLOSSNONSCAR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_HAIRLOSSNONSCAR | 1.293 [1.01, 1.66] | 0.046 |
| Birth year | 0.992 [0.98, 1.0] | 0.074 |
During the follow-up period (1.1.1998 — 31.12.2019), 78 out of 1581 females with L12_HAIRLOSSNONSCAR died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have L12_HAIRLOSSNONSCAR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.144% | No data |
| 5 | 0.728% | No data |
| 10 | 1.747% | No data |
| 15 | 3.274% | No data |
| 20 | 5.749% | No data |
Relationships between endpoints
↥Index endpoint: L12_HAIRLOSSNONSCAR – Other nonscarring hair loss
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data